openPR Logo
Press release

Cumulative Growth In Drug Discovery Is Expected To Boost Cell-Based Assay Market In Forecast Period

02-06-2018 03:26 PM CET | Health & Medicine

Press release from: Pharamceutical

Cumulative Growth In Drug Discovery Is Expected To Boost

Cell-based assay refers to experiments based on living cells and is an influential tool in the research lab. Cell-based assays are vital for understanding cellular mechanism in a biological context as these assays provide information about intracellular molecular targets. There are variety of assays used to measure motility, toxicity, cell proliferation, production of a measurable product, and morphology. Cell-based assays provides accuracy in obtaining the data of various parameters of the real-life model as live cells are used, cell-based assays are now used in drug discovery and checking the toxicity of new or old drugs used by population. With the rapid growth of pharmaceutical and biotechnological sector worldwide and emerging development of new drugs, the demand for cell-based assay is expected to witness a rapid increase. Companies are adopting the cell-based assay order to reverse the costly late-stage drug failure and thus the rising surge of cell-based assay is expect to have a positive effect on market growth in near future.
Cumulative growth in drug discovery is expected to boost Cell-based assay market in forecast period
Rapid growth in drug discovery is expected to increase the demand for cell-based assay as it is mainly used in checking toxicity of drugs. For instance according to FDA’s Center for Drug Evaluation and Research (CDER) in 2016, CDER approves averagely 30 novel drugs per year and the development of novel drug discovery is expected to increase in future. Many companies are involved in the drug discovery needs cell-based assay for testing new drugs that is expected to boost the cell-based assay market in forecast period. Since pharmaceutical market have become a billion-dollar business, many pharmaceutical and biotechnological companies are adopting cell-based assay in order to reduce the chances of failure of batch which lead to a high loss to company. Thus, the adoption of this method by companies is expected to fuel its market in near future. However, high maintenance, need for skilled personnel and high-cost of operation for the cell based assays are expected to hinder the market growth.

Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/1273

North America is expected to dominate Cell-based assay market due to growing pharmaceutical sector in region
Regional segmentation of cell-based assay market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is expected to hold a dominant position in the cell-based assay market due to rapid growth of pharmaceutical and biotechnology manufacturing sector. According to a study published in International Trade Administration in 2016, U.S. is a major hub for drug manufacturing and the market is expected to grow drastically in future which is expected to fuel cell-based assay market in North America. Asia pacific is expected to follow North America market in upcoming period of time due to increase in pharmaceutical and biotechnological sector in China and India which will increase the demand for cell-based assay and fuel its market in forecast period.
Discoverx Corporation launched in-cell pulse cell-based assays for confirmation of compound-target engagement in drug discovery
Major key players in Cell-based assay market are Discoverx Corporation, Becton, Dickinson and Company, cell Signaling Technology, Inc., Becton, Danaher Corporation, Thermo Fisher Scientific, Inc., Cisbio Bioassays, Merck & Co., Qingdao Haier Co., and PerkinElmer, Inc. and others. DiscoverX Corporation, one of the leading supplier of cell-based assay in 2016 introduced InCELL Pulse target engagement platform that provides scientists with the ability to generate their own cell-based target engagement assays for confirming compound cell entry and target binding in the native cellular environment.

Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/cell-based-assay-market-1273

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cumulative Growth In Drug Discovery Is Expected To Boost Cell-Based Assay Market In Forecast Period here

News-ID: 933796 • Views: 272

More Releases from Pharamceutical

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast

All 5 Releases